UniMed Center — East Brunswick, New Jersey

UniMed Center is a clinical research site located in East Brunswick, New Jersey, United States 08816.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

UniMed Center has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Peripheral Neuropathy, Chronic Low Back Pain, Type 2 Diabetes.

Sponsors: Eli Lilly and Company, Frontier Biotechnologies Inc., Meridian Bioscience, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in East Brunswick

Browse all research sites in New Jersey · View every site in East Brunswick

• Astera Cancer Care
• Astera Cancer Care East Brunswick
• Research Site
• START New Jersey
• Regional Cancer Care Associates
• START, Astera
• Titan Health Partners LLC, d/b/a Astera Cancer Care /ID# 221003
• Central Jersey Oncology Center
• Astera Cancer Center
• GSK Investigational Site
• Regional Cancer Care Associates, Central Jersey Division

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UniMed Center?

UniMed Center has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UniMed Center conducted?

UniMed Center has 6 clinical trials on record, with 1 currently active. Their work covers Diabetic Peripheral Neuropathy, Chronic Low Back Pain, Type 2 Diabetes.

Is UniMed Center accredited by Crixeo Clinical Trials?

UniMed Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UniMed Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.